Abbott Labs Pulls Obesity Drug Over Heart Risk
The obesity drug Meridia has been withdrawn from the U.S. market because of an increased risk of heart attack and
Read moreThe obesity drug Meridia has been withdrawn from the U.S. market because of an increased risk of heart attack and
Read moreTwo new studies add to the growing body of research about the many health benefits of consuming blueberries. Researchers from
Read moreThe diabetes drug Avandia, shown to raise heart attack risk by 40 percent in a paper published in the
Read moreGrowing awareness about the prevalence and risks of vitamin D deficiency is leading more and more doctors to test their
Read moreNew U.S. Pandemic Plan Aims to Speed Products “At a moment when the greatest danger we face may be a
Read moreThe U.S. Food and Drug Administration (FDA), the federal agency responsible for approving medical devices, is calling for stricter rules
Read moreThe FDA has issued a warning that the risk of severe muscle and kidney damage from the cholesterol drug simvastatin
Read moreHeart failure is a progressive condition marked by a worsening of the heart’s ability to pump enough blood to supply
Read morePeter Pronovost, MD, PhD, is a professor of anesthesiology and critical care medicine at the Johns Hopkins University School of
Read moreResearchers in the U.K. are questioning the effectiveness of a $387 million a year heart screening program started in the
Read more